In one paragraphArticle in Journal of internal medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jeffrey Shi Kai ChanCardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China.ORCID 0000-0003-0231-2393 Oscar Hou In ChouCardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China.ORCID 0000-0001-7058-4708 Teddy Tai Loy LeeCardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China.ORCID 0000-0001-9688-1348 Yan Hiu Athena LeeCardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China.ORCID 0000-0003-0740-1598 Raymond Ngai Chiu ChanCardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China.ORCID 0000-0002-1678-9128 Edward Christopher DeeDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0001-6119-0889 Kenrick NgDepartment of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0001-9132-4075 Tong LiuTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.ORCID 0000-0003-0482-0738 Gary TseTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.ORCID 0000-0001-5510-1253 Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4MHong Kong Metropolitan University RIF/2022/2.2NCI NIH HHS P30 CA008748Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-029A
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Cardiovascular DiseasesImmune Checkpoint InhibitorsCohort StudiesHumansRetrospective StudiesImmune Checkpoint Inhibitors
Identifiers
PMID38013596
PMCPMC11388562
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390